| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$556 |
Update - Notification of buy-back - RG1
|
16 Jan 2026 9:10AM |
$2.430 |
$2.300 |
fallen by
5.35%
|
|
| American Tungsten and Antimony Ltd (AT4) ORDINARY FULLY PAID |
Materials |
$182 |
Massive Stibnite Intersected at Antimony Canyon - Amended
|
16 Jan 2026 9:10AM |
$0.165 |
$0.140 |
fallen by
15.15%
|
|
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$49 |
Lady Loretta Mine Acquired Increasing Copper Pipeline
|
16 Jan 2026 9:08AM |
$0.105 |
$0.093 |
fallen by
11.90%
|
|
AR1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Austral Resources Australia Ltd (AR1) is focused on copper exploration and mining.
- The company has acquired interests in the Lady Loretta Mining Lease to enhance its copper pipeline.
- Lady Loretta Mine was previously focused on zinc but now offers potential for copper development.
- The acquisition enables a pit wall cutback into known copper mineralisation at Lady Annie pit, extending into Lady Loretta lease.
- Austral plans to integrate Lady Loretta tenure into existing geological and mining models.
- Near-mine drilling and technical assessments are planned to assess additional copper feed opportunities.
- The integration of Lady Loretta is expected to support pit cut back and extension opportunities.
- Austral aims to build a mid-tier copper powerhouse in Australia with dual processing capabilities for copper oxides and sulphides.
- Mining at Lady Annie cutback is scheduled to begin in Q2 2026.
- Austral Resources has a significant copper inventory and plans extensive exploration and development programs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MEC Resources Limited (MMR) ORDINARY FULLY PAID |
Energy |
$8 |
Options Placement Offer - Timetable extension
|
16 Jan 2026 9:04AM |
$0.006 |
$0.005 |
fallen by
25%
|
|
| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Market Update
|
16 Jan 2026 9:02AM |
$0.160 |
$0.100 |
fallen by
37.50%
|
|
WNX - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY26 EBITDA improved by $2.4 million compared to prior period.
- Gross margin increased from 22.8% to 31.3%.
- Group operating at breakeven as of Q2 FY26 close.
- Pain Away sales reached $3.3 million with a 7.6% gross margin improvement.
- Market share for Pain Away increased by 3 percentage points year-on-year.
- Priceline secured new distribution deals for additional SKUs.
- Costco Australia and New Zealand to trial exclusive heat patches.
- Company focuses on strengthening planning discipline and sustainable operating model.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$259 |
Orthocell Finalises Strategic Investment in Marine Biomedica
|
16 Jan 2026 9:01AM |
$1.015 |
$0.955 |
fallen by
5.91%
|
|
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$594 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
16 Jan 2026 9:01AM |
$1.050 |
$1.085 |
risen by
3.33%
|
|
AUC - Price-sensitive ASX Announcement
Full Release
Key Points
- Ausgold Limited completed an updated Definitive Feasibility Study for the Katanning Gold Project.
- The project is expected to have a mine life of 10.3 years with an increase in gold production.
- The updated study reflects increased production, reduced operating costs, and enhanced financial returns.
- A major $90 million capital raising was undertaken to support project development.
- Key contracts for the workforce accommodation facility and other pre-development activities are progressing.
- Ongoing exploration activities with a focus on expanding the existing resource base.
- The project entered the WA Government’s Priority Approvals Program for streamlined permitting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dotz Nano Limited (DTZ) ORDINARY FULLY PAID |
Information Technology |
$23 |
Date of AGM and Director Nominations
|
16 Jan 2026 8:55AM |
$0.039 |
$0.033 |
fallen by
15.38%
|
|
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$31,520 |
Form 8-K - RSS
|
16 Jan 2026 8:54AM |
$12.950 |
$68.210 |
risen by
426.72%
|
|
| Metals X Limited (MLX) ORDINARY FULLY PAID |
Materials |
$1,276 |
Rentails Concentrator FEED Package Award
|
16 Jan 2026 8:49AM |
$1.255 |
$1.440 |
risen by
14.74%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$726 |
Update - Notification of buy-back - RF1
|
16 Jan 2026 8:48AM |
$3.550 |
$3.450 |
fallen by
2.82%
|
|
| Fat Prophets Global Contrarian Fund Limited (FPC) ORDINARY FULLY PAID |
Financials |
$46 |
Update - Notification of buy-back - FPC
|
16 Jan 2026 8:48AM |
$1.480 |
$1.635 |
risen by
10.47%
|
|
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,352 |
Notification of ceasing to be a substantial holder - MQG
|
16 Jan 2026 8:46AM |
$0.980 |
$1.028 |
risen by
4.85%
|
|
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$28,670 |
Update - Notification of buy-back - ALL
|
16 Jan 2026 8:42AM |
$57.660 |
$46.790 |
fallen by
18.85%
|
|
| Qube Holdings Limited (QUB) ORDINARY FULLY PAID |
Industrials |
$8,886 |
Update in relation to MAM Due Diligence Process
|
16 Jan 2026 8:40AM |
$4.750 |
$5.020 |
risen by
5.68%
|
|
QUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Qube Holdings Limited announced an update regarding the due diligence process with Macquarie Asset Management.
- Macquarie Asset Management provided the necessary confirmation to continue the exclusivity period under the Process Deed.
- The Process Deed was initially entered into on 23 November 2025.
- Further information about the Macquarie Asset Management proposal was previously announced on 24 November 2025.
- There is no guarantee that the proposal will result in a binding offer for Qube shareholders to consider.
- Qube Holdings Limited will continue to provide updates about the proposal as necessary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,699 |
Update - Notification of buy-back - FLT
|
16 Jan 2026 8:39AM |
$15.180 |
$12.700 |
fallen by
16.34%
|
|
| Treasury Wine Estates Limited (TWE) ORDINARY FULLY PAID |
Consumer Staple |
$3,706 |
Becoming a substantial holder
|
16 Jan 2026 8:35AM |
$5.100 |
$4.590 |
fallen by
10%
|
|
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$113 |
First and Final Dividend - Pluton Resources
|
16 Jan 2026 8:34AM |
$0.028 |
$0.044 |
risen by
57.14%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,766 |
Net Tangible Asset Backing
|
16 Jan 2026 8:25AM |
$4.180 |
$4.370 |
risen by
4.55%
|
|
| James Hardie Industries Plc (JHX) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$20,105 |
James Hardie to Optimize Manufacturing Footprint
|
16 Jan 2026 8:24AM |
$34.990 |
$34.660 |
fallen by
0.94%
|
|
JHX - Price-sensitive ASX Announcement
Full Release
Key Points
- Closure of Fontana, California, and Summerville, South Carolina facilities.
- Expected annualized cost savings of $25 million from fiscal year 2027.
- Initiatives part of the Hardie Operating System for operational excellence.
- One-time pre-tax charges estimated at $40 to $44 million.
- Guidance for third quarter and full year of fiscal 2026 reaffirmed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brookside Energy Limited (BRK) ORDINARY FULLY PAID |
Energy |
$40 |
Update - Notification of buy-back - BRK
|
16 Jan 2026 8:22AM |
$0.400 |
$0.410 |
risen by
2.50%
|
|
| Australian Ethical Investment Limited (AEF) ORDINARY FULLY PAID |
Financials |
$567 |
Second Quarter FUM and Business Update at 31 December 2025
|
16 Jan 2026 8:22AM |
$4.990 |
$4.980 |
fallen by
0.20%
|
|
AEF - Price-sensitive ASX Announcement
Full Release
Key Points
- Funds under management totaled $14.08 billion as of 31 December 2025.
- There was a 1% decrease in FUM due to negative investment performance and an institutional outflow.
- Organic retail and wholesale net flows were positive, driven by superannuation growth.
- The company completed an administrative transition to GROW, improving cost efficiencies.
- Australian Ethical built a strong middle market pipeline for investment products.
- Implementation of the Charles River platform is underway to improve investment operations.
- The company was recognized for its leadership in ethical investing with awards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurizon Holdings Limited (AZJ) ORDINARY FULLY PAID |
Industrials |
$7,045 |
Ceasing to be a substantial holder
|
16 Jan 2026 8:22AM |
$3.600 |
$4.110 |
risen by
14.17%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$54 |
Canadian patent secured for PromarkerEso test for EAC
|
16 Jan 2026 8:22AM |
$0.775 |
$0.325 |
fallen by
58.06%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Proteomics International Laboratories Ltd (ASX: PIQ) secured a Canadian patent for its PromarkerEso test for esophageal adenocarcinoma (EAC).
- The patent provides intellectual property protection in Canada until 17 November 2035.
- PromarkerEso is a first-in-class blood test utilizing biomarkers to assess the risk of EAC.
- The test combines four key serum glycoproteins with patient clinical factors to generate a risk score for EAC.
- EAC represents a significant global health challenge with a five-year survival rate of less than 20%.
- The patent supports future commercial opportunities in North America, including direct sales and licensing.
- The test has demonstrated high accuracy in clinical studies for early EAC detection.
- Patent protection for PromarkerEso extends to multiple jurisdictions including Australia, China, Europe, and the USA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$208 |
Update - Notification of buy-back - ATA
|
16 Jan 2026 8:21AM |
$0.645 |
$0.560 |
fallen by
13.18%
|
|